720 filings
DEFA14A
BAX
Baxter International Inc.
27 Mar 24
Additional proxy soliciting materials
4:33pm
DEFA14A
BAX
Baxter International Inc.
25 Mar 24
Additional proxy soliciting materials
8:35am
DEF 14A
BAX
Baxter International Inc.
Definitive proxy
25 Mar 24
8:31am
8-K
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
PRE 14A
BAX
Baxter International Inc.
Preliminary proxy
14 Mar 24
4:31pm
8-K
han93w5ffa5enz0lstx
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
qznl4lw
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
tgz7r6p
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
9py0abvmf1x55bakat41
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
ywfxnn3wt 3th5lo0y
2 Oct 23
Completion of Acquisition or Disposition of Assets
9:02am
8-K
yyl9ux795mr4g4
21 Aug 23
Baxter Announces Updates to Its Board of Directors
5:03pm
8-K
0q2x6lmn4gti6yf2vr1n
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
5invkvf 76nvl5
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
tarua2dq5wehzf3ds
29 Jun 23
Baxter Appoints William Ampofo to Its Board
4:18pm
SD
pe7tqu5nj0ivw6jc9x
31 May 23
Conflict minerals disclosure
4:36pm
8-K
8vfpqtp2d
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
fqteochp ay77cszj
4 May 23
Submission of Matters to a Vote of Security Holders
4:45pm